Promore Pharma is a biopharma-ceutical company with headquarters in Stockholm, Sweden.
The company has several clinical stage programs in the field of advanced wound care. The corporate group has achieved Phase II data in three of its programs.
The company is managed as a small virtual R&D group, developing its programs in business alliances with global strategic partners.
Promore Pharma also evaluates other strategic partnering opportunities as they occur, and welcomes interest from potential partners in any ongoing project.
Promore Pharma’s vision is to develop two first-in-class product families with uses in broad applications in biosurgery and wound healing, specifically in indications with very few efficacious prescription pharmaceuticals.
The area of advanced wound care represents a business area of more than 15 billion USD in annual sales. Promore Pharma estimates its two main product families to have a combined peak sales potential of more than EUR 1 billion.
Click the link below to fill out a short contact form and we will be in touch with you shortly.